Trio Pharmaceuticals announced it raised $1.91 Million in an amended filing from an offering of $2.4 Million
Dec 13, 2022•about 3 years ago
Amount Raised
$1.91 Million
Round Type
seed
San DiegoBiotechnology
Company Information
Company
Trio Pharmaceuticals
Location
11956 Bernardo Plaza Drive, Suite 160
San Diego, California, United States
About
TRIO Pharmaceuticals, Inc. is a cancer immunotherapeutics company pioneering bispecific antibodies for the treatment of cancer with unprecedented potency and selectivity. TRIO’s innovative antibody drugs directly stop tumor growth without affecting normal cells and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. TRIO is developing a proprietary platform of dual-action tumor immunity-enhancing drugs aimed at treating cancers of high unmet medical needs by targeting specific antigens on the cancer cells and immunosuppressor cells. TRIO has an experienced team that has developed first-in-class FDA-approved drugs.
San Diego